Cipla stock: First-quarter revenue reaches INR 70.77 billion

Published on 10/19/2026 at 17:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-quarter revenue rose 8.19 percent to INR 70.77 billion. Cipla stock costs INR 1,324.10 on October 19, 2026, down 0.08 percent on NSE.

Revenue and valuation details

First-quarter fiscal year 2027 revenue reached INR 70.77 billion, 8.19 percent above the prior quarter.
Cipla's price-to-earnings ratio stood at 31.75 on October 19, 2026.
Cipla stock last stood at INR 1,324.10 on October 19, 2026 at 3:29 p.m. IST, down 0.08 percent on NSE.
Cipla's next results are scheduled for October 27, 2026.

Cipla, INE059A01026, Illustration mit AI erstellt.

Cipla's revenue reached INR 70.77 billion in the first quarter of fiscal year 2027, up 8.19 percent from INR 65.41 billion in the previous quarter, according to Cipla. Cipla stock last stood at INR 1,324.10 on October 19, 2026 at 3:29 p.m. IST, down 0.08 percent from the INR 1,325.10 prior close on NSE.

Revenue sets the operating baseline

The quarterly comparison gives investors a fresh operating reference before Cipla reports its September quarter. Revenue increased by INR 5.36 billion from the fourth quarter of fiscal year 2026, while the latest quarter ended June 30, 2026.

The finance statement for the first quarter also recorded INR 7.89 billion in net income and INR 10.99 billion in operating income. Those figures belong to the June 2026 quarter and provide the earnings baseline for the next report.

Stock remains below its yearly high

Cipla's NSE price is INR 348.90 below the 52-week high of INR 1,673.00 and INR 158.40 above the 52-week low of INR 1,165.70, both as of October 19, 2026. The distance to the high is 20.86 percent, calculated from the latest price and the high.

The company carried a market capitalization of INR 1.1 trillion and a price-to-earnings ratio of 31.75 as of October 19, 2026. Its trailing dividend yield was 0.01 percent. These figures place valuation alongside the operating data rather than replacing it.

Results date is October 27

Cipla's next board meeting is scheduled for October 27, 2026, to consider unaudited results for the quarter and half-year ended September 30, 2026, according to Bsenexus. The date is the next scheduled checkpoint for revenue, profit and margin trends.

Comparison with peers

Cipla (NSE, INR): down 0.08 percent, P/E 31.75, market capitalization INR 1.1 trillion
Sun Pharmaceutical Industries (NSE, INR): down 0.90 percent, P/E 34.58, market capitalization INR 4.2 trillion
Dr. Reddy's Laboratories (NSE, INR): up 0.77 percent, P/E 31.29, market capitalization INR 1.0 trillion

Price and trading position

The small daily decline leaves Cipla between its 52-week boundaries, with the next earnings date providing the clearest scheduled reference point. The stock's market value is lower than Sun Pharmaceutical Industries but close to Dr. Reddy's Laboratories on the same trading day.

Cipla's last available NSE price was INR 1,324.10 on October 19, 2026 at 3:29 p.m. IST, down 0.08 percent versus the prior close of INR 1,325.10.